ABSTRACT
Background:
The US population ≥65 years old is rapidly growing. Geriatric disorders including hip fractures are becoming more numerous and the medical cost is significant. Hip fractures increase the risk of mortality in geriatric patients, but with improvements in medical care, this risk is declining over time. One important factor in the recovery and rehabilitation of hip fracture patients is pain management. Understanding the impact of opiate prescribing practices on outcomes in the rehabilitation setting can guide recommendations for the future.
Materials and Methods:
Patients ≥65 years old with hip fracture undergoing rehabilitation were retrospectively reviewed within the electronic health record. Information regarding gender, age, height, weight, BMI, length of stay, type of fracture, weight-bearing status, and comorbidities such as coronary artery disease, heart failure, chronic obstructive pulmonary disease, dementia, diabetes, renal disease, and vitamin D deficiency were obtained. The patients’ morphine milligram equivalents were calculated and averaged by length of stay. This information was analyzed with the GG score along with patient-specific information above to assess for a relationship using odds ratio and Wald confidence intervals.
Results:
Of the studied ≥65-year-old patients (n = 115), the amount of MME weakly positively correlated, with the change in GG score for MME/day (P = 0.01), mobility (P = 0.02) and self-care (P = 0.03) scores. Age >85 years old (P = 0.002) and BMI <25 (P = 0.046) correlated with lower MMEs/day. Negative correlation with GG improvement was seen for age (P = 0.002), dementia (P < 0.001), and avitaminosis D (P = 0.01). Age (P = 0.001), dementia (P < 0.001), and avitaminosis D (P = 0.03) also correlated negatively with mobility, while only dementia (P < 0.001) and avitaminosis D (P = 0.004) correlated negatively with an overall score. Weight-bearing status displayed the most consistent positive correlation with overall (P = 0.009) and mobility (P = 0.04) scoring. Isolated positive impacts were seen with ‘unknown’ fracture types on mobility (P = 0.04), femur fractures on self-care (P = 0.047), and pubic rami fractures on self-care (P = 0.04).
Conclusions:
A weak but significant correlation was seen between treatment with opioids and change in rehabilitation scoring. Age, dementia, and avitaminosis D correlated negatively in this rural, geriatric population, consistent with previous findings, while weight-bearing status and type of fracture had more positive correlations with functional scoring.
Keywords: Acute rehabilitation, functional assessment, geriatrics, hip fracture, morphine milligram equivalents
Introduction
In 2010, the US population ≥65 years old was projected to reach 20.9% by 2050.[1] Census results from 2020 reveal this population is already 16.0%, bringing with it an increase in geriatric syndromes.[2] While hip fracture incidence is impacted by the use of bisphosphates, overall numbers of hip fractures are projected to reach 840,000 by 2040 with an expected acute hospitalization cost of USD 6 billion.[3,4] Of these fractures, 86% occur in individuals ≥65 years old.[3,5] Studies show hip fractures are more costly than other osteoporotic fractures, nearly tripling a patient’s yearly cost of a fracture-free year.[6] When acute care and nursing home services are included, annual costs for hip fractures are USD 8 billion annually.[7] Neither estimate examines the loss of wages and other indirect costs of hip fracture endured by the family which can be substantial. Mortality costs of hip fractures can also be significant, however, 2005 Medicare claims show a decline in 1-year mortality rate from hip fracture to 21.9% [24.0% in 1986] for women and 32.5% [40.6% in 1986] for men.[3] This is thought to be related to changes in the management of hip fractures including timely surgical intervention, improved surgical devices, early weight-bearing exercise, interdisciplinary care, and increased discharge to rehabilitation centers rather than to home.[3,8]
Pain management is an important factor in the care of hip fractures and lack of control can lead to delirium, depression, delayed ambulation, pulmonary complications, and delayed transitions of care to lower levels of care including acute rehabilitation units.[9] It is well known that adequate pain control for various musculoskeletal disorders results in greater functional recovery, but studies use multiple techniques.[9,10,11,12] The techniques used to control pain are variable in the peri-operative period, but once patients are discharged to rehabilitation, physical therapy, and topical and oral analgesia are more commonly used. There has been much discussion in the literature on the prescription of opioids versus non-opioid analgesia.[12,13,14,15,16] Opiate prescribing practices are continuously changing, shaped in large part by the opioid epidemic in the United States.[17] Opioids have accounted for 80,816 overdose deaths in 2021, up from 70,029 in 2020.[18] While the geriatric population has been less effected by overdose deaths, they may be contributing to the epidemic by receiving and unintentionally distributing prescribed opioids.[14,19] Controlling pain in patients is a continuous struggle for physicians. Evidence suggests that the risks of opiates exceed the benefits of chronic pain treatment.[20] The effectiveness of opiates in acute pain is stronger, but its superiority to non-opioid pharmacotherapy is not conclusively proven.[12,16,21]
Rehabilitation goals in geriatrics include improved completion of activities of daily living and instrumental activities of daily living. Within the acute rehabilitation setting, this is measured by the GG score which was implemented in 2016 as a transition away from the functional independence measure (FIM) and other functional measures to a universally utilized tool in inpatient rehabilitation, skilled nursing facilities, home health, and long-term care hospitals.[22] Factors that may hinder rehabilitation goals have been previously assessed and include age, previous functional status, dementia, frailty, delirium, pre-operational nutritional status, depression, etc.[23,24,25] Uncontrolled pain can also contribute in many ways to reduced functional improvement following hip fracture.[9,11] Since pain control is often obtained with the use of opiates, the risks need to be weighed against the benefits. Risks of opiate use in geriatric patients can be greater than the younger population due to pharmacokinetic and pharmacodynamic changes associated with age.[26,27] Side effects include nausea, constipation, urinary retention, sedation, cognitive impairment, and dizziness which can affect over half of geriatric patients who use opiates.[27] To this point, no studies have been performed to describe a correlation between the amount of opiates measured in morphine milliequivalents (MME) and functional improvement during rehabilitation. This is important to guide clinicians in the use of opiates in rehabilitation of the older adults. Family medicine and other primary care providers often manage these patients in skilled settings, so knowing the factors, such as pain management, that correspond with greater success in functional recovery can improve outcomes. This study examines a retrospective correlation between MME and its effect on performance in rehabilitation, as measured by activities of daily living via GG, in older adults recovering from a hip fracture.
Materials and Methods
A retrospective review of the electronic health record was conducted to provide a descriptive analysis of rural seniors (≥65 years old) with femur and pelvis fractures and the impact of MME on inpatient rehabilitation. Demographic data obtained included gender, age, body mass index, and selected comorbidities: coronary artery disease, heart failure, chronic obstructive pulmonary disease, dementia, diabetes, renal disease, and vitamin D deficiency. Also collected were length of stay, type of fracture, and weight-bearing status. A patient’s daily MME was averaged, by summing the MME of the total stay and dividing it by the length of stay. Patients were evaluated with the GG per the practice of the institution and the Center for Medicare and Medicaid Services standardized functional assessment requirement. The GG is a standardized scoring system that evaluates activities of daily living (ADLs) and reports them as total, mobility scores and self-care scores.[22] Admission and discharge scores were obtained and analysis was conducted on the change between these GG scores. As this was a retrospective study, providers did not adjust their treatment practices.
Statistical analyses were performed using SAS9.4. A binary logistic regression model was built with the targeted variables of MME use. Predictor variables were age, BMI, gender, fracture side, fracture location, fracture type, weight-bearing status, and comorbidities of cardiac disease, lung disease, dementia, diabetes, renal disease, and vitamin D deficiency. The effects that were significantly associated with the target variable (P < 0.05) were identified and the odds ratio and their Wald confidence intervals were reported. Specific demographics were analyzed for their association with low (0–10 MME) or high (>10 MME) by simple t-tabled chi-square. The correlation was calculated by Pearson correlation. This project was approved by Marshall IRB (2027586-1).
Results
Demographic data for studied patients ≥65 years (n = 115) was categorized based upon average MME per day [Table 1]. Most patients fell into the either 0.1–10 MME/day (38 patients) and 10.1–20 MME/day (32 patients) groupings. Patients requiring no MME were the only group with fewer females than males (41.67%; P = 0.083) and a normal BMI (23.5; P = 0.046). Groups using less MME (0 MME/day and 0.1–10 MME/day) tended to be above 85 years and have a BMI lower than 25, as the amount of MME/day correlated negatively with age (P = 0.002) and positively with a normal BMI (P = 0.046). Lung disease was more prevalent in groups requiring higher MME/day (20.1–30 = 22.2% and >30 = 28.0%; P = 0.004).
Table 1.
Demographics of Studied Population Separated by MME
MME | Overall | 0 | 0.1–10 | 10.1–20 | 20.1–30 | >30 | P |
---|---|---|---|---|---|---|---|
Number | 115 | 12 | 38 | 32 | 16 | 17 | |
Gender (percent female) | 64.35% | 41.67% | 71.05% | 65.63% | 68.75% | 28.82% | P=0.083 |
Age (years) | 78.29 | 82.2 | 82.7 | 79.3 | 73.3 | 68.8 | P=0.002 |
BMI | 26.19 | 23.5 | 25.6 | 26 | 27.3 | 28.7 | P=0.046 |
Type of fracture | |||||||
Femur | 101 | 75.00% | 89.47% | 90.63% | 93.75% | 82.35% | |
Pelvis | 14 | 25.00% | 10.53% | 9.38% | 6.25% | 17.65% | P=0.528 |
Weight bearing status | |||||||
Non-weight Bearing | 7 | 8.33% | 2.63% | 9.38% | 0.00% | 11.76% | |
Paris weight bearing | 13 | 8.33% | 10.53% | 12.50% | 18.75% | 5.88% | |
Weight bearing at time | 95 | 83.33% | 86.84% | 78.13% | 81.25% | 82.35% | P=0.941 |
Comorbidities | |||||||
CAD/CHF | 30 | 16.67% | 20.69% | 20.00% | 16.67% | 20.00% | |
COPD | 19 | 8.33% | 8.62% | 5.00% | 22.22% | 28.00% | |
Dementia | 13 | 0.00% | 12.07% | 12.50% | 0.00% | 4.00% | |
Diabetes | 28 | 16.67% | 15.52% | 25.00% | 16.67% | 16.00% | |
ERSD/Dialysis | 10 | 0.00% | 10.34% | 5.00% | 5.56% | 4.00% | |
Vitamin D Deficiency | 53 | 58.33% | 32.76% | 32.50% | 38.89% | 28.00% | |
Length of Stay (Days) | 13.95 | 13.9 | 14.2 | 14.1 | 13 | 14 | |
GG | |||||||
Total | |||||||
Admit | 41.88 | 41.2 | 42 | 41.3 | 43.3 | 42.4 | |
Change | 54.58 | 53.5 | 48.9 | 53.7 | 59.8 | 64.8 | |
Mobility | |||||||
Admit | 22.7 | 23.2 | 23.2 | 21.3 | 23.8 | 22.8 | |
Change | 38.41 | 27.6 | 37.6 | 38.5 | 41.9 | 45.9 | |
Self-care | |||||||
Admit | 18.98 | 18.1 | 18.7 | 19.7 | 19.5 | 19.6 | |
Change | 15.56 | 15.9 | 14.1 | 15.1 | 17.9 | 18.9 |
While all groups scored similarly on all three GG entry scores, the amount of MME/day trended positively with the change in scores over the course of the treatment period. Pearson correlation measurements demonstrated low correlation for MME/day for change in overall (0.24; P = 0.01), mobility (0.23; P = 0.02), and self-care (0.20; P = 0.03) scores [Table 1].
Table 2 lists the impact of those demographics on the overall and specific components of the GG. Age correlates negatively with a decrease per year of age of 0.52 for the overall score (P = 0.002) and 0.44 for the mobility score (P = 0.001). The presence of dementia and vitamin D deficiency correlate negatively throughout all components of the score; with the former decreasing the overall score by 25.01 (P < 0.001), the mobility score by 18.51 (P < 0.001), and the self-care score by 7.59 (P < 0.001) and the latter decreasing the scores 9.19 (P = 0.009), 6.13 (P = 0.03) and 3.03 (P = 0.004) respectively. Relative positive impact on scoring was seen for weight bearing as tolerated in mobility scoring 10.40 (P = 0.04) and partial weight bearing across all three scores 36.53 (P = 0.004), 27.94 (P = 0.005), and 9.84 (P = 0.01). Weight-bearing status was the most consistent grouping, having a significant impact on overall (P = 0.009) and mobility (P = 0.04) scoring. Isolated positive impacts on score were seen with ‘unknown’ fracture types on mobility scoring (8.43; P = 0.04), femur fractures on self-care scoring (8.03; P = 0.047), and pubic rami fractures on self-care scoring (8.71; P = 0.04).
Table 2.
Correlation of MME with Rehabilitation Scoring
Total GG | Mobility | Self-Care | |
---|---|---|---|
MME/Day | |||
Pearson | 0.23562 | 0.22787 | 0.20486 |
P | 0.0112 | 0.0148 | 0.0295 |
Total MME | |||
Pearson | 0.26518 | 0.20403 | 0.19932 |
P | 0.0209 | 0.0294 | 0.0343 |
Discussion
Prescribing analgesic medications is a standard practice in the rehabilitation setting. The juxtaposition of the need for pain control and the risks both to an aging population and the presence of the opioid epidemic have questioned the practice of prescribing opioids versus non-opioid.[13,14,15] Very little in the literature has sought to discover correlations between the amount of opioid use MME and rehabilitation performance scores among older adults recovering from a hip fracture.
Within our population [Table 1], patients not requiring opioid analgesia during their rehab stay, tended to be less female (41.67%), as all other MME groupings were predominately female. That group was also the only one with a normal BMI (23.5), while the other groups were overweight which increased with each MME grouping. Age negatively trended with MME groupings similarly to a recent study reviewing the relationship between pain intensity and analgesic use in hip fracture patients.[28] Vitamin D deficiency was proportionally higher in the lower MME groupings, which is understandable as they were the oldest groupings. Finally, all three initial ratings of functional scoring were similar, demonstrating that the level of impairment was similar between groups. Changes in each aspect of the GG score (mobility, self-care, and overall) do positively trend with the amount of MMEs/day utilized [Table 1]. The literature does recognize associations with positive rehabilitation outcomes and patient ambulatory ability and ability to participate in physical and occupational rehabilitation.[8] Higher levels of pain preclude patient willingness or ability to participate in the tasks required to return to functional status. The higher levels of MME found in our results likely equates to better pain control, which allows better participation in the rehabilitation process. This correlation is not described in a study examining 163 patients recovering from unilateral trochanteric fractures of the femur as they found no association between analgesic use as (measured in MME) and functional outcomes (measured by GG scores),[28] but is described as a factor influencing mobility in a separate study on 143 post-surgical hip fracture patients.[29]
Other significant correlations are seen between GG scoring and the demographics of age, weight-bearing status, vitamin D, and dementia [Table 2]. As in Table 3, age correlates negatively with a decrease per year of age of 0.52 (P = 0.002) for the overall and 0.44 (P = 0.001) for the mobility scores. This correlates with prior studies indicating age as a poor prognostic factor regarding functional status after hip fracture.[24] The presence of dementia and vitamin D deficiency comorbidities correlate negatively throughout all components of the score. Decreases are seen by 25.01 (P < 0.001) in overall, 18.51 (P < 0.001) in mobility, and 7.59 (P < 0.001) in self-care scoring when dementia was present [Table 3]. Previous research has shown that individuals with dementia are 21 times more likely to be bedridden in the immediate post-operative period in comparison to their non-dementia counterparts which may be a factor in this negative association since the ability to bear weight seemed to correlate positively with improved functional status.[23] The diagnosis of vitamin D deficiency correlated with smaller, but still significant, decreases in the overall (9.19; P = 0.009), mobility (6.13; P = 0.03), and self-care (3.03; P = 0.004) scoring [Table 3]. Similarly, vitamin D supplementation has been examined in post-stroke rehabilitation scores measured in functional independent measures (FIM) and revealed improvements in comparison to placebo, but does remains controversial.[30] A positive correlation was found for partial weight-bearing status compared to non-weight bearing, having impacts of 36.53 (P = 0.009) points on overall, 27.94 (P = 0.04) on mobility, and 9.84 (P = 0.01) on self-care scoring [Table 3]. These agree with prior studies indicating patients with outside impediments to rehab participation, such as dementia or poor weight-bearing status, or indicators of frailty, such as increased age or vitamin D deficiency, perform worse and struggle to rehabilitate post-fracture.[8,23,24,30]
Table 3.
Impact of Demographic Factors on GG Scoring
Overall GG Change | Estimate | Wald 95% CI | Chi Square | P | Significant Finding Meaning |
---|---|---|---|---|---|
Age (years) | −0.52% | −0.85 to−0.20 | 10.09 | 0.002 | Each year older decreases the score by 0.52 |
Boss mass index | −0.23 | −0.75 to 0.29 | 0.75 | 0.39 | |
Gender (female) | 2.51 | −4.76 to 9.78 | 0.46 | 0.50 | |
Fracture site | 1.07 | 0.59 | |||
Fracture Location | 12.64 | 0.18 | |||
Fracture type | 5.10 | 0.28 | |||
| |||||
Weight bearing status vs. NWB | |||||
| |||||
16.03 | 0.009 | ||||
PWB | 36.53 | 11.54 to 61.52 | 8.21 | 0.004 | PWB increases the score to 36.53 |
WBAT | 11.29 | −1.20 to 23.78 | 3.14 | 0.08 | |
| |||||
Comorbidities | |||||
| |||||
Coronary/Heart failure | 2.40 | −5.29 to 10.08 | 0.37 | 0.54 | |
Constructive lung disease | −2.66 | −12.52 to 7.20 | 0.28 | 0.60 | |
Dementia | −25.01 | −35.39 to 14.64 | 22.33 | <0.001 | Dementia lowers the score to 25.01 |
Diabetes | −5.69 | −13.36 to 1.99 | 2.11 | 0.15 | |
ESRD/Dialysis | −2.79 | −14.27 to 8.69 | 0.23 | 0.63 | |
Vitamin D | −9.19 | −16.03 to−2.36 | 6.95 | 0.009 | Vitamin D deficiency lowers the score to 9.19 |
| |||||
Mobility GG Change | Estimate | Wald 95% CI | Chi-Square | P | Significate Finding Meaning |
| |||||
Age (years) | −0.44 | −0.70 to−0.19 | 11.73 | 0.001 | Each year older decreases the score to 0.44 |
Body mass index | −0.23 | −0.64 to 0.18 | 1.21 | 0.27 | |
Gender (female) | 2.74 | −3.03 to 8.51 | 0.87 | 0.35 | |
Fracture side | 1.17 | 0.56 | |||
Fracture Location | 12.75 | 0.17 | |||
Fracture type | 6.14 | 0.19 | |||
| |||||
Weight bearing status vs. NW | |||||
| |||||
17.47 | 0.04 | ||||
PWB | 27.94 | 8.33 to 47.56 | 7.79 | 0.005 | PWB increases the score to 27.94 |
WBAT | 10.40 | 0.59 to 20.21 | 4.32 | 0.04 | WBAT increases the score to 10.40 |
| |||||
Comorbidities | |||||
| |||||
Coronary/Heart failure | 3.28 | −2.76 to 9.31 | 1.13 | 0.29 | |
Constructive lung disease | −1.52 | −9.58 to 6.55 | 0.14 | 0.71 | |
Dementia | −18.51 | −26.66 to−10.36 | 19.80 | <0.001 | Dementia lowers the score to 18.51 |
Diabetes | −5.49 | −11.55 to 0.56 | 3.17 | 0.08 | |
ESRD/Dialysis | −4.32 | −13.33 to 4.69 | 0.88 | 0.35 | |
Vitamin D | −6.13 | −11.51 to−0.76 | 5.00 | 0.03 | Vitamin D deficiency lowers the score 6.13 |
| |||||
Self-care GG change | Estimate | Wald 95% CI | Chi-Square | P | Significant finding meaning |
| |||||
Age (years) | -0.08 | −0.17 to 0.02 | 2.35 | 0.13 | |
Body mass index | 0.00 | −0.15 to 0.16 | 0.00 | 0.97 | |
Gender (female) | 0.01 | −2.20 to 2.18 | 0.00 | 0.99 | |
Fracture site | 1.36 | 0.51 | |||
Fracture Location | 2.86 | 0.29 | |||
Fracture type | 2.86 | 0.58 | |||
| |||||
Weight bearing status vs. NWB | |||||
| |||||
10.30 | 0.07 | ||||
PWB | 9.84 | 2.30 to 17.39 | 6.54 | 0.01 | PWB increases the score to 9.84 |
WBAT | 1.00 | −0.273 to 4.72 | 0.27 | 0.60 | |
| |||||
Comorbidities | |||||
| |||||
Coronary/Heart failure | −0.53 | −2.84 to 1.78 | 0.20 | 0.65 | |
Constructive lung disease | −1.50 | −4.57 to 1.57 | 0.92 | 0.34 | |
Dementia | −7.59 | −10.84 to−4.35 | 21.07 | <0.001 | Dementia lowers the score to 7.59 |
Diabetes | -0.07 | −2.37 to 2.23 | 0.00 | 0.95 | |
ESRD/Dialysis | 0.87 | −2.61 to 4.34 | 0.24 | 0.62 | |
Vitamin D | −3.03 | −5.07 to−0.98 | 8.41 | 0.004 | Vitamin D deficiency lowers the score 3.03 |
Table 3 displays the impact that different factors have on the scoring for overall, mobility and self-care GG scoring. Significant findings within larger categories include an 8.43-point increase to mobility scoring of unknown fracture type. (P=0.04), and both an 8.03 point and 8.71-point increase in self-care scoring for femur fracture (P=0.047) and rami fracture
The main limitation of this data is that it is retrospective, which only allows the evaluation of what factors are associated with differing levels of opioid use during the rehabilitation stay but not causation. While understanding these associations is important, randomized studies would be necessary to determine if there is a causative relationship between higher MMEs and improved rehabilitation scoring. The correlation between MME/day and changes in all levels of GG scoring is significant, but low. This likely represents the relatively small sample size of this single-site study. It does provide a footstool to spark future research, which should focus on conducting this analysis in larger facilities of differing geographic region, size, and governance.
Conclusion
There has been recent momentum to decrease the prescribing practice of opioids. Our data, however, demonstrates there may be a place for some opioid analgesia in improvement in rehabilitation performance and return to functional status in patients with hip fracture. This likely represents the need for adequate analgesia for patients to perform optimally in rehabilitation efforts. Sometimes this analgesia may need to be in the form of opioids. To maintain responsible stewardship of opioid use, future research should target the relative efficacy of opioid analgesia versus other analgesic modalities.
Other correlations with functional outcomes seem to be related to age, vitamin D deficiency, dementia, and weight-bearing status. This has been previously demonstrated.[23,24,30] Rehabilitation potential is an important variable in the risk-benefit analysis of patient care. Identification of factors that can lead to hindrance and improvement of these goals could weigh heavily on decisions made by providers. The impact on pain control on these negative predictors could pose as an important topic for further studies.
Conflicts of interest
There are no conflicts of interest.
Acknowledgements
We, the authors, would like to thank Jing Tian, MD for the calculations for this project and Michelle Peters, MAT for the organization, research and formatting that were essential for the completion of the project.
Funding Statement
Nil.
References
- 1.US Census Bureau PD. Projections of the Population by Selected Age Groups and Sex fror the United States: 2015-2060 (NP2012-T2). In. US Census Bureau. 2012 [Google Scholar]
- 2.US Census Bureau. United States. Older Population. 2020. [[Last accessed on 2022 Jun 28]]. Available from: https://data.census.gov/cedsci/profile?q=United%20States&g=0100000US .
- 3.Schnell S, Friedman S, Mendelson D, Bingham K, Kates S. The 1-year mortality of patients treated in a hip fracture program for elders. Geriatr Orthop Surg Rehabil. 2010;1:6–14. doi: 10.1177/2151458510378105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Shchneirder E, Guarinik J. The aging of America impact on health care costs. JAMA. 1990;263:2335–40. [PubMed] [Google Scholar]
- 5.Brauer C, Coca-Perraillon M, Cutler D, AB R. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302:1573–9. doi: 10.1001/jama.2009.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Christensen L, Iqbal S, Macarios D, Badamgarav E, Harley C. Cost of fractures commonly associated with osteoporosis in a managed-care population. J Med Econ. 2010;13:302–13. doi: 10.3111/13696998.2010.488969. [DOI] [PubMed] [Google Scholar]
- 7.LJ M. Hip Fractures: A worldwide problem today and tomorrow. Bone. 1993;14:S1–8. doi: 10.1016/8756-3282(93)90341-7. [DOI] [PubMed] [Google Scholar]
- 8.Chudyk A, Jutai J, Petrella R, Speechley M. Systematic review of hip fracture rehabilitation practices in the elderly. Arch Phys Med Rehabil. 2009;90:246–62. doi: 10.1016/j.apmr.2008.06.036. [DOI] [PubMed] [Google Scholar]
- 9.Abou-Setta A, Beaupre L, Jones C, Rashiq S, Hamm MP, Sadowski CA, et al. Pain Management Interventions for Hip Fracture Internet. Agency for Healthcare Research and Quality (US) 2011 Report 11-EHC022-EF. [PubMed] [Google Scholar]
- 10.Xiao P, Zhu Y, Wu H, Li X, Wu Y, Qian Q. Efficacy of a multimodal analgesia protocol in total knee arthroplasty: A randomized, controlled tiral. J Int Med Res. 2010;38:1404–12. doi: 10.1177/147323001003800422. [DOI] [PubMed] [Google Scholar]
- 11.De Luca M, Ciccarello M, Martorana M, Infantino D, Mauro GL, Bonarelli S, et al. Pain monitoring and management in a rehabilitation setting after total joint replacement. Medicine (Baltimore) 2018;97:e12484. doi: 10.1097/MD.0000000000012484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dixon J, Ashton F, Baker P, Charlton K, Bates C, Eardley W. Assessment and early management of pain in hip fractures: The impact of paracetamol. Geriatr Orthop Surg Rehabil. 2018;9:2151459318806443. doi: 10.1177/2151459318806443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Santosa K, Hu H, Brummett C, Olsen MA, Englesbe MJ, Williams EA, et al. New persistent opioid use among older patients following surgery: A medicare claims analysis. Surgery. 2020;167:732–42. doi: 10.1016/j.surg.2019.04.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kaafarani H, K H, Moheb M, Kongkaewpaisan N, Jia Z, El Hechi MW, et al. Opioids after surgery in the united states versus the rest of the world: The international patterns of opioid prescribing (iPOP) multicenter study. Ann Surg. 2020;272:879–86. doi: 10.1097/SLA.0000000000004225. [DOI] [PubMed] [Google Scholar]
- 15.Daoust R, Paquet J, Moore L, Émond M, Gosselin S, Lavigne G, et al. Recent opioid use and fall-related injury among older patients with trauma. Can Med Assoc J. 2018;190:E500–6. doi: 10.1503/cmaj.171286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sobieraj D, Martinez B, Miao B, Cicero MX, Kamin RA, Hernandez AV, et al. Comparative effectiveness of analgesics to reduce acute pain in the prehospital setting. Prehosp Emerg Care. 2019;24:163–74. doi: 10.1080/10903127.2019.1657213. [DOI] [PubMed] [Google Scholar]
- 17.Elfein J. Drug overdose death rate in the United States in 2020, by State. Statista. 2022. [[Last accessed on 2022 Jul 26]]. Available from: https://www.statista.com/statistics/686415/top-ten-leading-states-concerning-death-rate-of-drug-overdose-in-the-us/
- 18.National Center for Health Statistics. U. S. Overdose Deaths In 2021 Increased Half as Much as in 2020 - But Are still Up 15%. National Center for Health Statistics. 2022. [[Last accessed on 2022 Jul 21]]. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm#:~:text=The%20new%20data%20show%20overdose%20deaths%20involving%20opioids,continued%20to%20increase%20in%202021%20compared%20to%202020. Updated 2022 May 11.
- 19.Hedegaard H, Minino A, Spencer M, Warner M. Drug overdose deaths in the United States, 1999-2020. NCHS Data Brief. 2021:1–8. [PubMed] [Google Scholar]
- 20.Dowel D, Haegerich T, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. Center for Disease Control and Prevention. Morbidity and Mortality Weekly Report. 2016. [[Last accessed on 2022 Jul 26]]. Available from: https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm . [DOI] [PubMed]
- 21.Prevention CfDCa. Clinical Guidance for Selected Common Acute Pain conditions. Centers for Disease Control and Prevention. Acute Pain. 2018. [[Last accessed on 2022 Jul 26]]. Available from: https://www.cdc.gov/acute-pain/index.html .
- 22.Li C, Mallinson T, Kim H, Graham J, Kuo Y, Ottenbacher K. Characterizing standardized functional data at inpatient rehabilitation facilities. JAMDA. 2022;23:1845–53. doi: 10.1016/j.jamda.2022.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Schuetze K, Eickhoff A, Rutetzki K, Richter P, Gebhard F, Ehrnthaller C. Geriatric patients with dementia show increased mortality and lack of functional recovery after hip fracutre treated with hemiprosthesis. Eur J Trauma Emerg Surg. 2020;48:1827–33. doi: 10.1007/s00068-020-01472-4. [DOI] [PubMed] [Google Scholar]
- 24.Arinzon Z, Fidelman Z, Zuta A, Peisakh A, Berner Y. Functional recovery after hip fracture in old-old elderly patients. Arch Gerontol Geriatr. 2004;40:327–36. doi: 10.1016/j.archger.2004.10.003. [DOI] [PubMed] [Google Scholar]
- 25.Dyer S, Perracini M, Smith T, Fairhall NJ, Cameron ID, Sherrington C, et al. Rehabilitation following hip fracture. In: Falaschi P, Marsh D, editors. Orthogeriatrics: The Management of Older Patients with Fragility Fractures. Internet. 2nd ed. 2020. [Google Scholar]
- 26.Chau D, Walker V, Pai L, Cho L. Opiates and elderly: Use and side effects. Clin Interv Aging. 2008;3:273–8. doi: 10.2147/cia.s1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jassal M, Egan G, Dahri K. Opioid prescribing in the elderly: A sytematic review. J Pharm Technol. 2020;36:28–40. doi: 10.1177/8755122519867975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Harmon E, Chong L, Marruso M. Factors associated with pain intensity and analgesic use during inpatient rehabilitation for hip fracture. Rehabil Psychol. 2025;70:46–54. doi: 10.1037/rep0000560. [DOI] [PubMed] [Google Scholar]
- 29.Yoryuenyong C, Jitpanya C, Sasat S. Factors influencing mobility among people post-surgery for hip fractures: A cross-sectional study. Belitung Nurs J. 2023;9:349–58. doi: 10.33546/bnj.2759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Torrisi M, Bonanno L, Formica C, Arcadi, Cardile D, Cimino V, et al. The role of rehabilitation and viatmin D supplementation on motor and psychological outcomes in poststroke patients. Medicine (Baltimore) 2021;100:e27747. doi: 10.1097/MD.0000000000027747. [DOI] [PMC free article] [PubMed] [Google Scholar]